Results 181 to 190 of about 700,872 (398)
Arthritis &Rheumatology, EarlyView.Objective This study aims to investigate the impact of nonsteroidal anti‐inflammatory drug (NSAID) intake on radiographic spinal progression in axial spondyloarthritis (axSpA), considering different NSAID types (COX‐2 inhibitors [COX2i] and nonselective NSAIDs [ns‐NSAIDs]) and disease subgroups (radiographic [r‐axSpA] and nonradiographic [nr‐axSpA ...
Murat Torgutalp +8 more
wiley +1 more source
5-year trends in the intention to quit smoking amidst the economic crisis and after recently implemented tobacco control measures in Greece [PDF]
, 2014 Sotiria Schoretsaniti +6 more
openalex +1 more source
The effectiveness of a video-based smoking cessation intervention focusing on maternal and child health to help Chinese expectant fathers quit smoking: an open-label, single-blind, three-arm, randomised controlled trial [PDF]
, 2020 Wei Xia +8 more
openalex +1 more source
Will Delay Discounting Predict Intention to Quit Smoking?
Experimental and clinical psychopharmacology, 2017 L. Athamneh, Jeffrey S. Stein, W. Bickel
semanticscholar +1 more source
Arthritis &Rheumatology, EarlyView.Objective We evaluated serious infection risk in offspring exposed to tumor necrosis factor inhibitors (TNFi) in utero, separated by TNFi timing and placental transfer ability. Methods Using MarketScan (2011–2021), we identified offspring born to mothers with chronic inflammatory diseases.
Leah K. Flatman +6 more
wiley +1 more source
Estimating the Smoking Ban Effects on Smoking Prevalence, Quitting and Cigarette Consumption in a Population Study of Apprentices in Italy [PDF]
, 2015 Luca Pieroni +7 more
openalex +1 more source
The Influence of Smoking on Breast feeding Among Women Who Quit Smoking During Pregnancy
Nicotine & Tobacco Research, 2017 H. Joseph +3 more
semanticscholar +1 more source
Arthritis &Rheumatology, Accepted Article.Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro +17 more
wiley +1 more source
Arthritis &Rheumatology, Accepted Article.Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli +4 more
wiley +1 more source